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ad absurdum,” was chosen because it calls attention to our
current troubled fiscal state. Some political and medical
leaders have curiously characterized this economic status
as “stable” and have commented that “physician income is
fine.” Reductio ad absurdum is a philosophical axiom that
is used to disprove a proposition by showing the absurdity
to which it leads when carried to its logical conclusion.2
The financing of vascular care is closely reaching that state.
THE PHYSICIAN ETHOS
In general, some physicians and surgeons prefer not to
talk about money or address business problems, and in a
way, this is unfortunate. Physicians usually enter the prac-
tice of medicine on the basis of altruistic or charitable
motives. Most doctors follow the example of the prover-
bial Good Samaritan, which has served as our hospital seal
since its founding in 1796.3 The Good Samaritan spirit is
to provide health care to all patients because most physi-
cians think that it is the patient’s basic right. There is an
inherent conflict, however, between the charitable mission
of physicians and their need to be compensated appropri-
ately for the services they provide. I first confronted this
dichotomy when I was a junior in high school. My local
family doctor, a wonderful caring man, in response to my
question about how a doctor was paid stated, “Don’t
worry about the money, just take care of your patients—
the money will come.” Such an answer might have been
fine 45 years ago, but I think as vascular surgeons, we do
have to give more attention to our reimbursement and its
consequences on personal finances.
Two phenomena that drive the cost of health care are
evident to the vascular surgeon: (1) the aging of the pop-
ulation and (2) the development of new technology.
Manton and Vaupel’s4 survey article clearly showed the
shift in the median age of the American population, which
will result in a greater number of elderly patients requiring
vascular care. In addition, as vascular surgeons, we are
deeply involved with the technology revolution, which on
the surface may appear to decrease the cost of therapy (eg,
endovascular treatment of aneurysms) because this tech-
nique can lead to a reduced hospital length of stay. This
form of technology, however, can also increase hospital
costs not only by escalating the demand for therapy but
also because of the costs of the device used. Vascular lab-
Until recently, the American economy enjoyed un-
precedented growth, and jobless rates had reached new
lows. The events of September 11th further depressed a lag-
ging financial performance. One sector of the economy,
however, continues to do poorly—health care. This sector
never experienced the bullish general economy and contin-
ues to splutter and remains in turmoil. For example, several
large physician practice groups in California have declared
bankruptcy. In the same state, primary care physicians may
earn only $60,000 a year, and out of necessity, some physi-
cians hold a second nonmedical job.1 Recently, the leading
health maintenance organization (HMO) in Massachusetts,
Harvard–Pilgrim Healthcare, was placed in state receiver-
ship to avoid bankruptcy. Older established academic med-
ical centers in Philadelphia (University of Pennsylvania) and
in Boston (Beth–Israel/Deaconess) have coped with oper-
ating losses in excess of $100 million per year. The latter
continues to lose significant amounts of money. Hospital
mergers of prestigious medical centers have been unwound
(eg, Stanford–University of California, San Francisco).
America persists in the middle of a health care crisis. 
Vascular disease plays an important role in health care
delivery because of the participation of both hospitals and
physicians in Medicare-funded treatment, which will be
accentuated by the growing elderly population. Young
surgeons entering the specialty of vascular surgery are con-
fronting declining reimbursement rates and, in turn,
reduced compensation for their services.
This paper will address this major crisis: the financial
state of physicians and hospitals, both of which provide
vascular care, as well as the implications of this financial
crisis. The problems confronting hospitals on the delivery
of vascular care will also be reviewed. The title, “Reductio
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OPINION
Reductio ad absurdum: Financing vascular care in
the millennium
Thomas F. O’Donnell, Jr, MD, Boston, Mass
oratory testing is another example of a technologic
advance, which may increase health care costs, but in a dif-
ferent way. This diagnostic tool has certainly uncovered a
greater prevalence of significant but asymptomatic carotid
disease than was not well appreciated by other techniques.
Treatment with carotid endarterectomy has increased
because of both improved detection of disease and the
efficacy of surgical treatment, as proven with prospective
randomized controlled trials.
HEALTH CARE COMPONENTS
The dynamics of health care and the relationships of its
components can be looked on as a triangle (Figure) with
the patient or employer (wholly or partially responsible for
paying health care premiums) at the top (the most impor-
tant component); the payors, at the bottom right; and
finally the providers, hospitals, and physicians at the bottom
left. For vascular surgeons, the federal government,
through Medicare, represents the major payor, where
Medicaid is a minor payor.5 HMOs are also important
because these payors provide access for the patient to health
care while reimbursing physicians for this care. HMOs play
a unique role for the vascular patient, because of their man-
aged care function either through risk or capitation.6 On
the left of the triangle, physicians and hospitals are the only
components that provide direct care to patients in contrast
to insurance organizations. Payors serve principally as a con-
duit for reimbursement, and in the case of managed care,
payors may also regulate a patient’s access to health care.
METHODS
For the examination of the current state of vascular
surgery’s role in health care, hospital discharges for vascu-
lar diagnosis-related groups in the state of Massachusetts
were reviewed for the period 1995 to 1999 through
Health Share Technology, as described previously.7 In
addition, hospital revenue, costs, and margin were ana-
lyzed with the Transition Systems, Inc, analysis of hospital-
based vascular services at New England Medical Center
during the same time period. Such detailed data are
unavailable statewide. The professional revenue of the
Vascular Service at New England Medical Center and
practice costs were examined for the years 1995 to 1999.
Finally, two national surveys of physician compensation,
the Medical Group Management Association Faculty
Practice Survey for the period 1996 to 20018 and the
Medical Economics 1999 Physician Reimbursement
Survey, were reviewed.9
The role of Medicare. Medicare has had a negative
impact on both hospitals, through the Balanced Budget
Act (BBA), and vascular surgeons, through revisions in
Resource-Based Relative Value Units. The net result is
that both providers receive reduced reimbursement for
delivering vascular care. The BBA has resulted in less rev-
enue per vascular case for hospitals because of the lower-
ing of indirect medical expenses, which is specific to the
diagnosis-related group. As shown previously, hospitals
and, in particular, academic medical centers (AMCs) have
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responded to the reduced revenue associated with BBA by
reducing both the length of stay and resource use.7 At
AMCs, these measures have led to an approximately 2% to
4% decrease in direct costs associated with providing vas-
cular care. AMCs, however, may be at the limit of their
capabilities to reduce costs further.
Surgeons play a minor role in health care costs because
they account for only 18% of total health care expendi-
tures. Vascular surgeons’ lives were changed in 1992 when
the Omnibus Budget Reconciliation Act introduced a new
method of payment for physician’s services by altering
Part B Medicare expenditures. Medicare is critical to the
vascular surgeon because it is (1) the source of approxi-
mately 70% of professional revenue, (2) the benchmark for
reimbursement by other payors, and (3) a dynamic tar-
get.10 Historically, the formula for the resource-based rel-
ative value scale (RBRVS) was related to several factors,
the most important being the estimate of work (time and
intensity) as originally proposed by Hsiao et al.11 Hertzer
and Noether,12 working with the Abt Company, refined
Hsiao’s estimate of work by relating one vascular proce-
dure to other common vascular procedures and thereby
constructed a tree of vascular procedures that was based
on the perceived procedure complexity. The other two
factors in the formula, practice expense and the cost asso-
ciated with professional liability, were multiplied by a geo-
graphic factor and a single conversion factor. Over time
the original formula has been altered greatly. Vascular sur-
geons have sustained substantial reductions in vascular
reimbursement, because RBRVS is flawed for the follow-
ing reasons. RBRVS is not truly resource based, and as one
of the individuals who had worked on the original Abt
study I would suggest that there is no cross-specialty rela-
tionship to other disciplines. All modifications in RBRVS
are linked to the original formula and changes in the
RBRVS and are politically unpopular. Furthermore, the
The health care triangle. Interaction among the three participants
in health care: the patient and his or her employer (top), who pay
the premiums; the federal and state governmental sources as well
as private insurers (bottom right); and finally, physicians and hos-
pitals (bottom left), who provide the care. In addition to reim-
bursing both the physicians and the hospitals, the payors can also
control access to physicians and hospitals in a capitated or risk
model.
practice expense component and revisions thereof disad-
vantage specialists like ourselves. In the end, vascular sur-
geons become disproportionately penalized. 
Several factors have led to reduced reimbursement for
vascular surgeons. The work value for vascular surgery,
when compared with other specialties, is set inappropri-
ately low. Eleven vascular case types were revised in 1996,
whereas in 1998 a single conversion factor led to a 9%
reduction in professional reimbursement from Medicare.
In addition, the practice expense factor was reduced by
11%, which was rationalized on the belief that vascular sur-
geons do not use their office extensively and care for their
patients principally in both the intensive care unit and hos-
pital setting. The net effect for three of our major proce-
dures, carotid endarterectomy, aortic aneurysm repair, and
infrainguinal bypass, has been a 30% reduction in reim-
bursement over the last several years. A recent proposal by
Medicare would reduce professional reimbursement for all
physicians in 2002 by an additional 5.4%. Obviously, vas-
cular surgeons, along with their collegues, are opposing
this legislatively. George Andros’ presentation at the E.
Stanley Crawford Critical Issues of California Surgeons
Symposium graphically documented these disturbing
changes where his survey of California surgeons described
an approximately $1500 decrease in reimbursement a
piece for carotid endarterectomy, aneurysm repair, and
infrainguinal bypass from 1986 to 1999.13 Andros suc-
cinctly typified the situation as “vascular surgeons are
working harder, but getting paid less.” His survey docu-
mented a 20% to 40% reduction in practice revenue and a
concomitant 10% to 50% increase in workload to compen-
sate for the decrease in revenue. 
Vascular surgeons and other physicians are experienc-
ing a reduction in income at a time when many other pro-
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fessionals, such as young lawyers, are enjoying an increase
in their compensation. For example, one major law firm in
Boston decided that to retain young associates, they
would increase pay for lawyers fresh out of law school.
Salaries rose to $140,000 per year.14 At the same time
young Internet entrepreneurs, some not out of college,
have become instant millionaires. In discussions with our
young faculty, it is obvious that this is a difficult economic
milieu for a vascular surgeon.
The vascular market. The volume trends for vascular
surgery must first be examined to understand the dynam-
ics of vascular finance. Volume trends for vascular proce-
dures are important because they detail market capacity.
Unlike the buffalo, which became extinct because it was
overhunted by a new powerful instrument, the rifle, vas-
cular procedures appear to be increasing (Table I).
Volume trends, as detailed by the National Hospital
Discharge Data survey, show that after a decline in the
1990s to 46,600 procedures per year there was a marked
rise in the number of carotid endarterectomies performed,
from 108,000 in 1995 to 144,000 in 1997, the last avail-
able data year (Table I).15 For the same period there was
a progressive increase in elective aneurysm repair from
24,000 in 1985 to 46,000 in 1997, a near doubling.
Although the number of infrainguinal bypass grafts
showed a relatively small increase from 82,000 to 87,000,
aortofemoral bypass grafting remained flat at approxi-
mately 28,000 procedures per year during that period. 
Vascular surgery volume trends in Massachusetts, how-
ever, demonstrated a different pattern (Table II). From
1995 to 1999 there was a 4% decrease in the overall num-
ber of the four major vascular procedures.7 The only 
procedure that increased in Massachusetts was infrain-
guinal bypass grafting (+ 2%). Although aortofemoral
Table I. National volume trends in vascular procedures15 (000)
1985 1990 1994 1995 1996 1997
Procedure
Carotid endarterectomy 61.3 46.6 — 108 — 144
Elective aortic aneurysm 24 36 — 39 — 46
Infrainguinal bypass graft — — 82 — 95 87
Aortofemoral bypass graft — — 28 — 23 28
Table II. Vascular procedure volume trends in the state of Massachusetts 1995-19997 (percent changed)
Carotid
Infrainguinal AAA repair Aortofemoral endarterectomy Total
1995-1999 % change (overall) 2 4* 16* 8* 4*
AMC 5* 5* 7*
Community hospital 7 36* 1*
Proportion done in AMC 33
1995 29 38.5 33.3 31 31
1994 38.1 31 31.6 30.6
*Negative or decrease in percentage.
AAA, Abdominal aortic aneurysm; AMC, academic medical center.
bypass grafting decreased by 16%, most likely because of a
shift to catheter-based procedures, the 8% reduction in
carotid endarterectomy is perplexing. The decrease in
Massachusetts’ vascular procedures may be related to some
of our older retired patients moving to the warmer south
or west. This population shift has been documented with
1999 census bureau data, which show a 6% reduction in
the segment aged 65 to 74 years in New England over the
past decade.16 The consequences of this population shift is
best exemplified by what has happened to the Veterans
Affairs (VA) system in Boston where some of you have
trained. The Boston VA Hospital has been converted into
an outpatient facility and consolidated with the West
Roxbury VA hospital to become Boston’s sole inpatient VA
facility. By contrast, a large VA facility has been constructed
in North Palm Beach consistent with 1999 census trends
that showed a 6% population growth in the Medicare gen-
eration for the South Atlantic region. 
The other unique phenomenon about Massachusetts is
that 42% of health care is provided in AMCs, which is about
fourfold greater than the situation in the rest of the United
States. Five high vascular volume AMC’s, New England
Medical Center, Massachusetts General Hospital, Brigham
& Women’s, Beth Israel/Deaconess, and the University of
Massachusetts Memorial, account for anywhere from 30%
to 40% of all major vascular procedures done in the state 
of Massachusetts. Carotid endarterectomy served as the
index procedure for defining a high-volume center—more
than 60 carotid cases per year. Other than a shift in the pro-
portion of infrainguinal bypass grafts to a greater number
done in community hospitals, the proportion of vascular
surgical procedures carried out in academic medical centers
has been stable (Table II). Community hospitals in
Massachusetts, however, have observed a dramatic 36%
decrease in the number of elective abdominal aortic
aneurysm repairs. The impact of fellowship-trained vascular
surgeons in larger community hospitals is best characterized
by comparing the growth in carotid endarterectomy, elec-
tive aneurysm repair, and infrainguinal bypass grafting at
the Winchester and Cape Cod Hospital where there has
been a marked increase in the decade of the 1990s (R.
Weiner, Winchester Hospital, and R. S. Scarpato, Cape Cod
Hospital, written communication).
VASCULAR SURGEON COMPENSATION
Unfortunately, compensation for academic vascular
surgeons is in free fall. The overall changes are most
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marked for vascular surgery in private practice, where aver-
age compensation decreased $35,000 from $309,000 in
1997 to $275,000 in 2000. Recuctions in academic vas-
cular surgeon compensation paralleled their private prac-
tice colleagues. Median salaries for assistant professors
declined $7,000 over 4 years from $190,000 in 1996 to
approximately $183,000 in 2000,8 whereas associate pro-
fessors’ salaries fell from approximately $250,000 to
$238,000, both uncorrected for inflation. Over this 4-year
period, inflationary changes of 3%/year further magnify
this drop in compensation. Several factors influence a sur-
geon’s compensation. Surgeons in group practice, where
compensation is on a 100% productivity basis, may receive
$30,000 more than a surgeon on a straight-salary basis.
The geographic site of practice also is important. Vascular
surgeons in the South make approximately $25,000 more
than surgeons who practice in the East and nearly $30,000
more than a surgeon practicing in the West. The latter
compensation level most likely reflects the greater pene-
tration of managed care on the West Coast with its atten-
dant reduced professional reimbursement. Specifically, the
presence of managed care greatly influences a surgeon’s
compensation. Surgeons receive $40,000 less in an area
that has more than a 50% penetration of managed care.17
There is a distinct contrast in the direction of com-
pensation trends between a vascular surgeon and that of a
“cognitive” specialist such as a psychiatrist, hematolo-
gist/oncologist, or gastroenterologist. Vascular surgeons
have sustained a 7% to 10% reduction in the average salary
for a faculty member over the period 1996 to 2000 as
opposed to the 8% to 24% increase in salaries for cognitive
specialists during that same time frame (Table III). This
difference is most likely related to the shift in compensa-
tion by the Health Care Finance Administration toward
enhancing the remuneration of cognitive specialists for
their office consultation at a time when compensation for
technically related or operative procedure–based special-
ties is decreased.
Professional income is related to two factors: profes-
sional revenue and practice costs. When the sources of rev-
enue for an academic surgeon are compared with that of a
private-practice surgeon, there are similarities in operating
room–derived revenue and in ambulatory or office visit
revenue. Both private and academic vascular surgeons staff
vascular laboratories. The private-practice vascular sur-
geons or their corporation, however, in compliance with
Stark I and II can derive a portion of the technical or facil-
Table III. Comparison of changes in vascular faculty salaries versus cognitive specialties (percent change 1996-2000)
Vascular
Asst Assoc Prof Psychiatry Hematology/oncology Gastroenterology Overall
–11* –10* –10* 7.8 21.1 24.1 9.7
*Negative or decrease in percentage.
Assoc, Associate; Asst, assistant; Prof, professor.
ity fees for vascular laboratory studies. In addition, the 
private-practice surgeon may be able to receive a portion
of other ancillary fees associated with an office-based prac-
tice. By contrast, academic vascular surgeons are compen-
sated in part for teaching residents (administration and
teaching component of Medicare) or for supervising hos-
pital areas such as the vascular laboratory or the operating
room. Finally, some academic surgeons may have income
related to research activity. When the productivity of these
two types of surgeons, as measured by gross charges, is
compared over the last 3 years, there appears to be little
difference between the private and the academic vascular
surgeon.8,9 Because 70% of revenue for clinical care, par-
ticularly from surgical procedures, is related to Medicare,
alterations in professional reimbursement associated with
Medicare are critical.5 As an index of clinical practices, a
comparison of gross changes shows a $700,000 increase
from 1997 for academic vascular surgeons ($965,310, FY
1997; $1,395,000, FY 2000). This underscores Andros’
contention that surgeons are working harder. From 1997
to 2001 there was a noticeable decline in Medicare com-
pensation for major vascular procedures (Table IV). For
example, reimbursement for aortic aneurysms declined
$335, femorotibial bypass graft, $636; femoropopliteal
bypass graft, $469; carotid endarterectomy, $200; aorto-
femoral bypass graft, $340; and arteriovenous access,
$150.18 Thus, there has been a significant decrease in pro-
cedural reimbursement, which again is related to the mod-
ification of the practice component and of the single
conversion factor (Table IV).
When the ratio of total compensation to clinical pro-
duction (the later determined by gross charges) of vascu-
lar surgeons is compared with that of cognitive specialists,
the ratio is twofold better for the latter than for vascular
surgeons (0.25, vascular surgeons, vs 0.59, cognitive spe-
cialists); that is, cognitive specialists receive a greater pro-
portion of their gross charges as salary.19 In addition, for
vascular surgeons, this ratio has worsened from its value
(0.26) in 1997. One of the major factors leading to this
difference may be that vascular surgeons accrue more
gross charges through their procedure-based practice than
cognitive specialists do. Certainly, office expenses are
unlikely to be greater with a vascular practice. When the
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average number of outpatient or ambulatory encounters is
compared between academic (1121, FY 2000) and pri-
vate-practice physicians (1257, FY 2000), academic vascu-
lar surgeons see fewer patients in the ambulatory setting.8
However, academic vascular surgeons have increased their
average ambulatory volume from FY 1998 (967). This
lower ambulatory volume may be related to a preselection
phenomenon. Academic vascular surgeons see a greater
proportion of patients who have been preselected for
surgery, usually by a referring surgeon. In contrast, the
private-practice vascular surgeon most likely sees patients
who are not undergoing an operation and may act as a
“primary care” vascular physician. Finally, when the indi-
vidual distribution of the various Current Procedural
Terminology categories is compared among three types of
surgeons, general, vascular, and cardiac, the “cognitive
role” of the vascular surgeon is evident. Nearly 50% of a
vascular surgeon’s ambulatory encounters are related to
the cognitive medicine/diagnostic category, whereas 25%
is for the surgery/anesthesia category. Cardiac surgeons,
however, spend a greater proportion of time in the oper-
ating room (52% surgery/anesthesia), which is probably
related to the presurgical evaluation and referral by cardi-
ologists. The “salary” of a private-practice vascular sur-
geon, expressed as the proportion of gross or net revenue
provided as compensation, is similar to an academic sur-
geon’s. The principal differences lie in the disposition of
the “surplus.” In an academic practice, surplus may be
used by the department for recruiting and for offsetting
other deficit divisions, retained by the vascular division for
“academic development” or used as a portion for incentive
payment to the specific surgeon. By contrast, in private
practice, the surplus may be placed in a deferred or direct
compensation plan.
RESPONSES TO THE DILEMMA
When either surgeons or hospitals are confronted with
such a financial crisis, two general responses are available:
(1) improvement of revenue or (2) reduction of costs.
Hospitals have more options than physicians. Hospitals can
strive to improve market share and the resultant revenue
gain through many avenues. In addition, the negative
impact on Medicare-related patient revenue (the major
Table IV. Typical changes in professional reimbursement 1995-1999
1995 1996 1997 1998 1999
Medicare ($)
Carotid endarterectomy 1431 1471 1526 1381 1320
Elective aortic aneurysm repair 2095 2119 2258 2058 1960
Femoropopliteal 1626 1689 1853 1704 1605
Femorotibial 1888 1994 2165 1980 1906
All payors, payor-mix weighted ($)
Carotid endarterectomy 1442 1446 1562 1452 1222
Elective aortic aneurysm repair 1982 2134 2021 1844 2024
Femoropopliteal 1935 1527 1526 1594 1680
Femorotibial 1947 1886 1849 2162 1956
payor for vascular care) of the BBA is being countered
politically. On the expense side, cost reduction is a neces-
sity for most hospitals. By contrast, surgeons have limited
opportunities for decreasing expenses, so they must
increase or at the least defend their market share (potential
patient volume), particularly versus other specialties.
Revenue can be enhanced by (1) increasing the amount of
dollars per unit worked (price of service, ie, increased reim-
bursement from a payor); (2) increasing market share (vol-
ume of services) or at the least defending against market
share reduction; and finally, (3) extending the range of ser-
vices offered. Alternatively, expense reduction for most sur-
geons is difficult to carry out because the possibilities are
limited. The focal area becomes the lowering of personnel
costs. It is hard to reduce the number of vital medical
employees in a practice, although some outsourcing may
be carried out. Finally, surgical practices are already low in
the total operating costs to total medical revenue ratio
(39%) versus internal medicine (54%) and primary care
(58%).8 This ratio reflects, in a way, the margin of a prac-
tice. Salary reduction for surgeons either in an academic or
in a private practice is painful, but may be the sole method
for “balancing the books.” Unfortunately, this alternative
has occurred in many practices out of necessity.
There are several strategies for improving revenue of a
vascular practice: (1) enhance revenue per case, (2) increase
the number of vascular cases (volume), or (3) capture
ancillary clinical revenue. Revenue for a vascular case may
be increased with both improvement of the work intensity
and appropriate Current Procedural Terminology coding.
As an indication of the vascular surgeon’s current focus,
courses on CPT coding have become an important feature
at national and regional vascular societies.
The number of vascular cases can be enhanced
through development of endovascular and interventional
vascular skills. At the least, market share erosion for vascu-
lar surgeons should be prevented by the preceding strat-
egy. The teaching of catheter-based skills to vascular
surgeons as organized by our societies is essential for pre-
venting the decline in a vascular surgeon’s volume. Finally,
ancillary revenue can be captured through the vascular
laboratory and by the development of wound or vein cen-
ters. Although there are several threats to a vascular sur-
geon’s revenue, the possession of endovascular techniques
by many other specialists represents the chief threat to loss
of market share for vascular surgeons. Interventional radi-
ologists, cardiologists, and vascular medicine specialists are
performing aortic and infrainguinal endovascular proce-
dures. A similar cadre of interventionalists, including neu-
rosurgeons, carry out carotid percutaneous transluminal
angioplasty/stent for carotid occlusive disease. In my
opinion, endovascular surgery could represent the vascular
surgeons’ Waterloo, unless it is appropriately addressed
and unless vascular leadership takes a strong stand. The
vascular societies must formulate a series of strategies to
strengthen the practice of endovascular surgery, particu-
larly when some have suggested that approximately 40% to
70% of open vascular procedures may be replaced with
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endovascular techniques. In the endovascular arena, vas-
cular surgeons compete with a coterie of catheter-based
specialists: cardiologists, radiologists, interventional neu-
roradiologists, and neurosurgeons. This crisis threatens
our very control of the vascular patient. Are these merely
“turf battles,” or does the growth of endovascular tech-
niques represent a potential losing battle for vascular
surgery like Waterloo was for Napoleon?
Vascular surgeons have certain advantages: a knowl-
edge of vascular disease, better technical skills, and in many
instances present control of the vascular patient.20 The lat-
ter factor is related to the vascular surgeon’s traditional
dual role in providing both diagnosis and treatment. In
addition vascular surgeons have some control over the vas-
cular laboratory and access to the operating room.
Unfortunately, many vascular surgeons currently have
poorly developed catheter-based skills. On the other hand,
cardiologists also can be viewed as controlling vascular
patients because of the referral of atherosclerotic disease in
one system—the heart, to them. Moreover, the population
growth of these other specialties can adversely affect the
competition for the vascular patient, so that vascular sur-
geon’s are progressively outnumbered. In contrast to the
residency review committee’s control of vascular fellow-
ships, the residency review committee apparently cannot
exercise the same degree of control over the number of car-
diology fellows. Currently, there is a great deal of contro-
versy in our national vascular societies over the vascular
surgeon’s appropriate role in endovascular treatment.
Many leaders such as Veith, Zarins, Fogarty, and Hobson
favor a major role for the vascular surgeon and have taken
an aggressive stand to promote endovascular skills for vas-
cular surgeons. There are some vascular leaders, however,
who think that vascular surgeons should not concern
themselves with endovascular surgery. I believe the latter
approach is wrong and will serve our specialty poorly in the
future.
There are three general options open to vascular sur-
geons in response to the potentially diminished market
share opportunities associated with endovascular proce-
dures: (1) organization of vascular centers, which usually
unite interventional radiologists with vascular surgeons21;
(2) the “do-it-all approach” as exemplified by Andros’
group in Burbank, California13; or finally, (3) as some
have argued, the cessation of the field to catheter-based
specialists. I think the latter alternative is dangerous,
because from an economic point of view, it limits the vas-
cular surgeon’s ability to maintain if not improve profes-
sional revenue. Moreover, it prevents the continuation of
a vascular surgeon’s traditional multifaceted role.
Certainly, for the surgeon in whose practice vascular pro-
cedures comprise only a portion of their workload, there
may be a shift to performing a greater proportion of the
more remunerative and less labor-intensive general surgi-
cal procedures.
The initial impetus to the organization of a vascular
center was based in the commonality of organ-specific ath-
erosclerotic problems, which cut across multiple disci-
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plines.22 Vascular centers provide a structure to facilitate
comprehensive care of the vascular patient. More recently,
the impetus to the formation of vascular centers may be
more related to the burgeoning catheter-based opportuni-
ties of other specialists.21 This phenomenon has driven
mergers of certain specialties, which in a sense co-opts the
competition. Vascular centers may not only improve the
revenue of vascular surgeons but also enhance the revenue
of interventional radiologists at the same time. After the
institution of a vascular center, Ouriel et al21 showed that
surgical procedures were reduced, but interventional pro-
cedures increased significantly. In addition, compensation
improved for vascular surgeons after the vascular center
was created.
Specialty centers such as vein or wound clinics that
address one specific vascular area represent another alter-
native for improving revenue and have a strong marketing
focus. One subtle drawback to specialty centers is the
emphasis on the entrepreneurial element or their “slick”
image. In conclusion, vascular surgeons may feel much
like the subjects in the Gericault painting The Raft of the
Medusa: they are left on a life raft in the middle of the
ocean surrounded by sharks. How will they survive? This
painting has several layers of meaning. When this ship was
sinking in the Atlantic, the only lifeboats were taken by the
captain and his senior officers. More than 150 passengers
and crew were left to use a makeshift raft. At the end of 13
days only 15 of them survived this ordeal. Although
Gericault was criticized initially for elevating such a com-
mon or topical subject to a heroic scale, eventually the
true meaning and the political relationship of the painting
were understood. As a noted historian and art critic stated,
“France herself and our whole society is on that raft.”23
Hopefully, the allegory does not apply now to vascular
surgery. Not only is procedural revenue decreasing so that
a vascular surgeon’s compensation is jeopardized, but also
the very meaning of what is “vascular surgery” is becom-
ing blurred.
SUGGESTED SOLUTIONS
At this point in the history of vascular surgery, we
need corrective strategies. The fundamental element of
this strategy is to define for patients who vascular surgeons
are and what we do. We must introduce a public market-
ing effort to our patients to educate them on the role of 
a vascular surgeon. Inherent to defining our specialty is
the need for a separate vascular board. Similar to the fac-
tors leading to development of the cardiothoracic board, a
new technical discipline, endovascular treatment, has
demanded this further definition of vascular surgery. A
distinct board will eliminate the confusion over who is a
vascular surgeon. If we want to clearly define our role as
vascular surgeons and distinguish ourselves from other
specialists, simply maintaining vascular surgery as a subset
of general surgery may not be the optimal strategy.
Vascular surgery will have a major problem with our
patients and referring physicians as long as we are not rec-
ognized as a distinct specialty with medical, surgical, and
catheter-based disciplines. Without a distinct board, vas-
cular surgery will not become a viable political and eco-
nomic force. Certainly, Winston Churchill symbolized the
fight against a greater threat for Western Civilization when
he united England and the allied forces. Churchill’s
famous “V” for victory sign can take on a modern day
meaning as a symbol: V for vascular surgery. We need the
same Churchillian resolution and fortitude. Indeed, a sec-
ond strategic action for vascular surgery is an enhance-
ment of our political and legislative voices both nationally
and regionally. That is why the Eastern Vascular Society
and other regional vascular societies are critical in reinvig-
orating our regional legislative action.
The third strategic focus is education. We need to pro-
mote educational programs on catheter-based skills for
practicing vascular surgeons by regional workshops or
attendance at special centers of excellence for teaching
endovascular skills. These centers need formal recognition
and “certification.” Finally, as educators of the next gen-
eration of vascular surgeons, we must examine critically
how we train our vascular fellows. The traditional 5 years
of general surgery plus 1 or 2 years of vascular fellowship
do not appear optimal for teaching the additional catheter-
based component of vascular surgery. We should be open
to a different configuration of “surgical” training to
achieve the end product of a knowledgeable vascular spe-
cialist. We are more than just vascular “surgeons.” We
diagnose, treat medically, insert catheters to both define
disease and render therapy, and finally, reconstruct surgi-
cally. We need to define ourselves more broadly as such
and provide the appropriate education for the next gener-
ation in our chosen specialty.
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